Navigation Links
Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males
Date:4/22/2009

Feedback Can Influence New Product Development and Innovation

MOUNTAIN VIEW, Calif., April 22 /PRNewswire/ -- The latest end-user study from Frost & Sullivan's Pharmaceuticals & Biotechnology group assesses a variety of critical dynamics of drug delivery approaches and technologies in cancer treatment. Physicians, nurses and patients provided insight on factors such as perception, usage, reconstitution, home vs. office administration parameters, and barriers of leading drug delivery types, providing insight and feedback to cancer treatment developers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Selected findings from the survey include the following:

  • Nearly half of cancer patients surveyed wanted home infusion to last less than 1 hour.
  • Infusion nurses expected greater change in prescribing trends for cancer drug treatment over the next 12-24 months than oncologists.
  • Cancer patients were highly satisfied with implantable fusion pumps and oral delivery. While 75 percent of patients conduct drug delivery by themselves or a family member, oncologists and infusion nurses prefer this process be conducted by a trained healthcare worker or caregiver.
  • Oncologists and infusion nurses prefer oral as the leading type for new drug development, although other types were highly valued such as implants, transdermal patches, and implantable infusion pumps

Through more than 240 detailed interviews with medical oncologists, infusion nurses and cancer patients (breast, colorectal, lung, prostate) in the U.S., research analysts identified key insights into drug treatment, utilization, and potential future approaches to drug delivery in oncology.

From the Analyst
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards
2. Frost & Sullivan Applauds SHL Telemedicine for Excellence in Product Innovation
3. Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture
4. Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications
5. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
6. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
7. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
8. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
9. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
10. Frost & Sullivan: In Vitro Diagnostics Market
11. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 Telomere Biosciences, LLC (Telomere Biosciences) ... for Dogs" with Telomerase Activation Complex , ... world for dogs. Telomeres are the protective caps ... body. A wealth of ground-breaking research by some ... and Aging, including Nobel laureates, has demonstrated a ...
(Date:8/21/2014)... , Aug. 21, 2014  Decision Resources ... Brazil and Mexico ... uptake of several newly approved agents, the anticipated ... indication and the launch of emerging biologics will ... In particular, the emerging IL-5 inhibitors will introduce ...
(Date:8/21/2014)... , Aug. 21, 2014 ... Immune Pharmaceuticals Inc., a biotechnology company, on its ... Immune previously traded on OTCQX®, the best marketplace ... OTC Markets Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... on the successful execution of its growth strategy ...
(Date:8/21/2014)... Aug. 21, 2014  Four-dimensional (4-D) printing develops ... on external stimuli such as changes in temperature. ... disruptive effect in multiple industries.  In the near ... by printing objects ranging from human organs to ... Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
Breaking Biology Technology:Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4
... Waukesha, Wis. - GE Healthcare has ... Research Excellence in Breast Cancer Imaging within the ... , ,With funding from GE Healthcare, a $17 billion ... is designed to advance and commercialize research and technology ...
... a meeting with U.S. Health and Human Services ... and healthcare organizations pledged to support health information technology ... health information technology products used by their health plans. ... effort to support a national initiative aimed at improving ...
... admitted his crystal ball may be a little cloudy, but he ... woes may have already trickled out in anticipation of the ... his Senate colleague and a software executive, isn`t sure the worst ... that the audit on state IT projects should be a catalyst ...
Cached Biology Technology:Wisconsin firms pledge to support healthcare IT standards 2Is the worst over for state technology failures? 2
(Date:8/21/2014)... Researchers from North Carolina State University have developed a ... The model has applications for creating new materials as ... , "Our new technique allows us to model much ... so much more quickly," says Nan Li, lead author ... student in NC State,s Department of Materials Science and ...
(Date:8/20/2014)... (HCI) at the University of Utah have identified and ... the unregulated enzyme driving the blood cancer chronic myeloid ... 6,000 new cases of CML will be diagnosed in ... inhibitors (TKIs), target BCR-ABL and are effective at controlling ... it in a way that allows patients to get ...
(Date:8/20/2014)... this image of the Para and Mato Grosso states ... intentionally set in order to deforest the land. Deforestation ... trees where the land is thereafter converted to a ... to farms, ranches, or urban use. The herringbone-patterned tan ... Rainforest in the middle of the image are evidence ...
Breaking Biology News(10 mins):Researchers develop models to study polyelectrolytes, including DNA and RNA 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... forming the droplets that make up clouds, a little ... much. And that,s good news for reducing the uncertainty ... essential for accurate climate modeling, and understanding cloud formation ... form when water vapor is attracted to particles floating ...
... name by successfully transplanting bioengineered stem cell-based trachea, composed of ... the technique to recreate more complex tissues, such as the ... lungs. He has also made an experimental attempt to regenerate ... news he will be presenting during his seminar at the ...
... national synchrotron facility, Diamond Light Source, is now the first ... 3 including serious viruses such as those responsible for ... analysed at atomic and molecular level using synchrotron light. This ... levels of detail and this new facility extends that capability ...
Cached Biology News:The role of goop: Research shows pollution doesn't change the rate of droplet formation 2The role of goop: Research shows pollution doesn't change the rate of droplet formation 3Stem cell-based bioartificial tissues and organs 2Diamond sheds light on basic building blocks of life 2Diamond sheds light on basic building blocks of life 3
... anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... dependent dilution. ICC: Use at an assay dependent ... - 10 ug/ml, this concentration is determined using ... weight: 40 kDa. Not tested in other applications. ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Anti human PPAR gamma2 mouse monoclonal antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: